CVS Health Corporation (CVS) is listed on NYSE in Retail Stocks. It is $93.05, +0.14%, with a $119.0B market cap. RSI is 35.3, near oversold. The latest reported quarter beat estimates. Insiders were net sellers across the listed trades.
Technical Analysis
RSI (14) 35.3 Near Oversold
Market Cap $119.0B
Volume 4.4M
Fundamentals — 10-Q Q2 2026
Revenue $206.5B
Net Income $5.9B
EPS $4.61
Gross Margin 44.7%
Operating Margin 4.5%
Net Margin 2.9%
P/E Ratio 20.2x
Earnings
Recent Insider Trades
| Name | Title | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| Robbins Larry | Insider | Sell | 3,372,000 | $94.15 | $317.5M | 2026 May 21 |
| Mandadi Tilak | EVP, Chief Exp & Tech Officer | Sell | 69,551 | $89.58 | $6.2M | 2026 May 8 |
| Finucane Anne A. | Director | Sell | 7,500 | $71.02 | $532,650 | 2025 Aug 20 |
| Sansone Guy P | Director | Buy | 1,570 | $63.70 | $100,009 | 2025 Jun 5 |
| Robbins Larry | Director | Sell | 3,750,000 | $67.66 | $253.7M | 2025 May 6 |
| Clark James David | SVP, Cont & Chief Acct Officer | Sell | 7,513 | $66.35 | $498,488 | 2025 Mar 5 |
| Mahoney Michael F | Director | Buy | 30,000 | $66.70 | $2.0M | 2025 Feb 18 |
| Capozzi Heidi B | EVP and Chief People Officer | Buy | 80 | $57.36 | $4,589 | 2024 Oct 23 |
| Mahoney Michael F | Director | Buy | 9,181 | $54.49 | $500,273 | 2024 May 2 |
| Ludwig Edward J | Director | Buy | 1,000 | $53.88 | $53,880 | 2024 May 2 |
| Shah Prem S | EVP and Pres-Pharm, Consumer W | Sell | 29,473 | $76.95 | $2.3M | 2024 Feb 16 |
| Ludwig Edward J | Director | Buy | 2,000 | $70.47 | $140,940 | 2023 Nov 3 |
| Clark James David | SVP, Cont & Chief Acct Officer | Sell | 25,759 | $74.92 | $1.9M | 2023 Aug 3 |
| Lynch Karen S | President and CEO | Buy | 14,000 | $69.75 | $976,500 | 2023 May 3 |
| Moriarty Thomas M | EVP & General Counsel | Sell | 137,466 | $98.36 | $13.5M | 2022 Dec 15 |
| Lotvin Alan | EVP&President-PharmacyServices | Sell | 143,440 | $98.94 | $14.2M | 2022 Aug 4 |
| Finke Daniel P | EVP/Pres, Health Care Benefits | Sell | 9,546 | $100.00 | $954,600 | 2022 Aug 3 |
| Moriarty Thomas M | EVP & General Counsel | Sell | 138,654 | $95.00 | $13.2M | 2022 Jun 28 |
| Shah Prem S | EVP and Co-President of Retail | Sell | 16,954 | $105.00 | $1.8M | 2022 Apr 8 |
| Finke Daniel P | EVP/Pres, Health Care Benefits | Sell | 61,300 | $100.12 | $6.1M | 2022 Apr 5 |
Other Retail Stocks
| Ticker | Price | RSI | Mkt Cap |
|---|---|---|---|
| | $266.39 | 55.8 | $2.9T |
| | $103.12 | 33.7 | $820.6B |
| | $945.67 | 49.5 | $419.4B |
| | $235.00 | 50.2 | $27.7B |
| | $344.82 | 51.5 | $83.7B |
| | $16.53 | 52.1 | $29.9B |
| | $517.57 | 50.5 | $22.1B |
| | $147.57 | 61.7 | $18.4B |
Take CVS further
- Browse Retail Stocks for the rest of the group, with what the businesses in it have in common and where they differ.
- Put CVS in a portfolio and see what it does to total return, drawdown, and how the rest of your holdings move with it. Compares against the S&P 500 over the same days, free and without an account.
- Screen for others like it by RSI, valuation, market cap, and insider activity.
- Check the earnings calendar for when CVS Health Corporation next reports.
Set alerts on CVS
Get notified when CVS Health Corporation hits your price targets or technical conditions are met.
Get Started Free